* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Entry slip BL 610B Congenital Heart Disease paper names _ Smith
Gene therapy wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Gene nomenclature wikipedia , lookup
Pathogenomics wikipedia , lookup
Essential gene wikipedia , lookup
Protein moonlighting wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Genetic engineering wikipedia , lookup
Quantitative trait locus wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Oncogenomics wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Gene expression programming wikipedia , lookup
Genomic imprinting wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Ridge (biology) wikipedia , lookup
History of genetic engineering wikipedia , lookup
Public health genomics wikipedia , lookup
Point mutation wikipedia , lookup
Genome evolution wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Minimal genome wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Designer baby wikipedia , lookup
Gene expression profiling wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Entry slip BL 610B Congenital Heart Disease paper names __________________ Smith, K.A. et al. (2009) Dominant-negative ALK2 allele associates with congenital heart defects. Circulation 119:3062-3069. Authors: where are these authors located? Summary/ Background. What is an atrioventricular septum (not described)? Problems in AVS development lead to heart disease, but what genes are involved? Congenital heart defects (CHD) can arise from many causes in development of primitive heart, but what are some signaling pathways that are implicated? Therefore, the authors used a candidate gene approach: they sequenced coding regions of 32 candidate genes that might be involved, comparing patients with CHD history and normal controls. What are cSNPs, and how can these help in genetic disease association studies? They found some novel cSNPs, in total ____ genetic lesions in _____ different genes predicted to affect protein function. They focused on the ALK2 gene. What does this gene do, and through what signaling pathway does it work? ** Presenters, please look up information (as from developmental biology) about how ALK2 and this signaling pathway work; where is ALK2 protein normally located, for example .. They tested the WT and altered ALK2 genes for function in new model organism,? _____________________ What is the scientific name of this organism? (not given)___________________________ What was their overall conclusion in the summary? What is a dominant-negative allele? Methods: how did they get the DNA and determine the sequences of 32 candidate genes? How did they determine which patients had CHD, versus normal controls? Results: How many patients with CHD were analyzed? ______ What did they find for the 32 genes analyzed? Some of the cSNPs had been found in normal people and were not interesting, namely ________ Other cSNPs were unique to the patients, namely ________. Computer programs predicted _____ of these cSNPs would affect protein function, of which _____ were patient-specific (the Table). Table: How many different genes were identified by these mutations affecting function? _____ Figure 1. They focused on the ALK2 gene, and had found 3 SNPs. Why did they only focus on L343P for the rest of the paper? Supplemental Figure 1. What did the pedigree analysis tell them about the cSNPs in ALK2? Fig. 2. They tested the activity of the WT ALK2 and various mutant proteins by constructing plasmids carrying the different genes. They introduced these genes into bovine endothelial cells in tissue culture and tested the activation of a Luciferase reporter with a BMP-responsive element in the promoter. They tested each ALK2 gene alone, or after inducing BMP6 protein. Controls were no ALK2 (vector), a known Dominant-negative mutation and CA, constitutively active variant. What did they find for the expression of the luciferase reporter in response to the different ALK2s +/- BMP? What did they find for kinase activity of the different variants? Fig. 3. Why did they introduce the different ALK2 constructs into the zebrafish embryos? How did they introduce the mutant sequences, and what did they observe and measure? What are the conclusions from Fig. 3? Why did they also do a Western blot (Fig. 3e,f)? Fig. 4. What did they find for the hearts of the zebrafish? And the effect of ALK2 L343P mutation? Overall conclusions, questions?